참고문헌
-
Bae, E. A., Park, S. Y., and Kim, D. H., Constitutive
${\beta}$ -glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol. Pharm. Bull., 23, 1481-1485 (2000) https://doi.org/10.1248/bpb.23.1481 - Bielory L., Complementary and alternative interventions in asthma, allergy, and immunology. Ann. Allergy Asthma Immunol., 93(2 Suppl 1), S45-54 (2004) https://doi.org/10.1016/S1081-1206(10)61486-X
- Choo, M. K., Park, E. K., Han, M. J., and Kim, D. H., Antiallergic activity of ginseng and its ginsenoside. Planta Med., 69, 518- 22 (2003) https://doi.org/10.1055/s-2003-40653
- Friedman, E. S., LaNatra, N., and Stiller, M. J., NSAIDs in dermatologic therapy: review and preview. J. Cutan. Med. Surg., 6, 449-59 (2002) https://doi.org/10.1007/s10227-001-0137-3
- Kim, D. H., Herbal medicines are activated by intestinal microflora. Nat. Prod. Sci., 8, 35-43 (2002)
- Kim, S. H., Lee, S. D., Kim, W. B., Lee M. G., and Kim N. D., Deter- mination of a new antiulcer agent, eupatilin, in rat plasma, bile, urine, liver homogenate by high performance liquid chromatography. Res. Commun. Mol. Path. Pharmacol., 97, 165-170 (1997)
- Kobashi, K. and Akao, T., Relation of intestinal bacteria to pharmacological effects of glycosides. Biosci. Microflora, 16, 1 - 7 (1997) https://doi.org/10.12938/bifidus1996.16.1
- Nicoloff, B. J., The cytokine network in psoriasis. Arch. Dermatol., 127, 871-884 (1991) https://doi.org/10.1001/archderm.127.6.871
- Plaut, M., Pierce, J. H., Whatson, C., Hanley-Hyde, J., Nordan, R. P., and Paul, W. E., Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilonRI or to calcium ionopore. Nature, 339, 64-67 (1989) https://doi.org/10.1038/339064a0
- Ryu, S. N., Han, S. S., Yang, J. J., Jeong, H. G., and Kang, S. S., Variation of eupatilin and jaceosidin content of mugwort, Korean J. Crop Sci., 50(S), 204-207 (2005)
- Sakuma, S., Higashi, Y., Sato, N., Sasakawa, T., Sengoku, T., Ohkubo, Y., Amaya, T., and Goto, T., Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system (Comparison with steroids). Int. Immunopharmacol., 1, 1219-26 (2001) https://doi.org/10.1016/S1567-5769(01)00059-5
- Schafer-Korting, M., Schmid, M. H., and Korting, H. C., Topical glucocorticoids with improved risk-benefit ratio. Drug Safety, 14, 375-385 (1996) https://doi.org/10.2165/00002018-199614060-00003
- Shin, Y. W., Bae, E. A., Kim, S. S., Lee, Y. C., and Kim, D. H., Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. Int. Immunopharmacol., 5, 1183-1191 (2005) https://doi.org/10.1016/j.intimp.2005.02.016
- Shin, T. W., Bae, E. A., Lee, B., Min, S., Lee, J. H., Baek, N. I., Ryu, S. N., Chung, H. G., Kim, N. J., and Kim, N. J., Antiallergic effect of Artemisia princeps SJ-1 and SS-1 cultivated in Ganghwado, Nat. Prod. Sci., 12, in press (2006)
- Simons, F. E. R., The antiallergic effects of antihistamines (H1- receptor antagonists). J. Allergy Clin. Immunol., 90, 705-715 (1992) https://doi.org/10.1016/0091-6749(92)90156-V
- Stevens, R. L. and Austen, K.F., Recent advances in the cellular and molecular biology of mast cells. Immunol. Today, 10, 381-386 (1989) https://doi.org/10.1016/0167-5699(89)90272-7
- Sugimoto, Y., Umakoshi, K., Nojiri, N., and Kamei, C., Effect of histamine H1 receptor antagonists on compound 48/80- induced scratching behavior in mice. Eur. J. Pharmacol., 351, 1-5 (1998) https://doi.org/10.1016/S0014-2999(98)00288-X
- Wuthrich, B., Epidemiology of the allergic diseases: are they really on the increase? Int. Arch. Allergy Appl. Immunol., 90 (suppl. 1), 3-10 (1989) https://doi.org/10.1159/000235067